- Home
- TAL vs CORT Comparison
TAL vs CORT Comparison
Compare TAL & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAL
- CORT
- Stock Information
- Founded
- TAL 2003
- CORT 1998
- Country
- TAL China
- CORT United States
- Employees
- TAL N/A
- CORT N/A
- Industry
- TAL Other Consumer Services
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- TAL Real Estate
- CORT Health Care
- Exchange
- TAL Nasdaq
- CORT Nasdaq
- Market Cap
- TAL 6.4B
- CORT 7.6B
- IPO Year
- TAL 2010
- CORT N/A
- Fundamental
- Price
- TAL $11.17
- CORT $75.15
- Analyst Decision
- TAL Buy
- CORT Strong Buy
- Analyst Count
- TAL 4
- CORT 4
- Target Price
- TAL $12.66
- CORT $139.00
- AVG Volume (30 Days)
- TAL 3.9M
- CORT 714.6K
- Earning Date
- TAL 10-30-2025
- CORT 11-04-2025
- Dividend Yield
- TAL N/A
- CORT N/A
- EPS Growth
- TAL 136.94
- CORT N/A
- EPS
- TAL 0.28
- CORT 0.87
- Revenue
- TAL $2,653,037,000.00
- CORT $741,172,000.00
- Revenue This Year
- TAL $34.61
- CORT $28.85
- Revenue Next Year
- TAL $23.90
- CORT $34.98
- P/E Ratio
- TAL $40.10
- CORT $86.48
- Revenue Growth
- TAL 44.45
- CORT 17.92
- 52 Week Low
- TAL $8.50
- CORT $49.00
- 52 Week High
- TAL $15.30
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- TAL 42.54
- CORT 48.84
- Support Level
- TAL $11.60
- CORT $70.74
- Resistance Level
- TAL $12.15
- CORT $79.89
- Average True Range (ATR)
- TAL 0.48
- CORT 3.49
- MACD
- TAL -0.13
- CORT 0.47
- Stochastic Oscillator
- TAL 3.82
- CORT 64.62
About TAL TAL Education Group
TAL Education Group is a smart learning solutions provider in China. It operates a few business lines including enrichment learning, high school academic tutoring, learning technology, and content solutions. Among those business lines, TAL focuses on enrichment learning and content solutions.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.